1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Johnson Matthey Pharma Services Acquires X-Zyme

M&A Deal Summary

Johnson Matthey Pharma Services Acquires X-Zyme

On April 11, 2011, Johnson Matthey Pharma Services acquired life science company X-Zyme

Acquisition Highlights
  • This is Johnson Matthey Pharma Services’ 1st transaction in the Life Science sector.

M&A Deal Summary
Date 2011-04-11
Target X-Zyme
Sector Life Science
Buyer(s) Johnson Matthey Pharma Services
Deal Type Add-on Acquisition

Target

X-Zyme

Duesseldorf,
X-Zyme, a leading biocatalysis company, provides a full range of enzymes for the manufacture of chiral alcohols. Statistics indicate that currently over 20% of pharmaceutical intermediates contain chiral alcohols.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Johnson Matthey Pharma Services

Devens, Massachusetts, United States
Category Company
Founded 1972
Sector Chemicals
Employees120
DESCRIPTION

Johnson Matthey Pharma Services, Inc. services encompass all areas of research, development and manufacturing, and allows you to realize your next series of milestones. Strong cGMP and regulatory compliance underscores our services for custom synthesis, process development, scale-up, optimization, and method validation

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: M&A 1 of 1
Year: 2011 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal